Table 4.
Variable | p | aOR Survival (95% CI) |
---|---|---|
PPV | <0.01 | 0.07 [0.02–0.19] |
Vasoactive infusion | <0.01 | 0.08 [0.03–0.24] |
Time period (2014–2018) | <0.01 | 4.44 [1.43–13.77] |
Dialysis | 0.01 | 0.12 [0.02–0.68] |
Transplant type/GVHD | ||
Autologous transplant | REF | 1 |
Allogeneic transplant without GVHD | 0.61 | 0.41 [0.01–12.71] |
Allogeneic transplant with GVHD | 0.36 | 0.19 [0.01–6.51] |
Infectious Complication | 0.56 | 0.72 [0.24–2.15] |
Transplant Indication | ||
Malignant Hematologic | REF | 1 |
Solid tumor | 0.84 | 0.70 [0.02–22.21] |
Non-malignant Hematologic | 0.50 | 0.60 [0.14–2.61] |
Immunodeficiency | 0.61 | 1.60 [0.26–10.00] |
Non-malignant other | 0.43 | 2.99 [0.20–45.37] |
aOR, adjusted odds ratio; CI, confidence interval; PPV, positive pressure ventilation; GVHD, graft-versus-host-disease; REF, reference group.